Konstantinos Papamichael

38PUBLICATIONS
74CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 02, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumab.

|Mar 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.

Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif

|Jan 28, 2026
Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease.

Alessandra Saraga, Tina Deyhim, Ajay Gade

|Nov 27, 2025
Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel Disease.

Sebastian Povlsen, Kamal Patel, Xavier Roblin

|Nov 17, 2025
Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease-Authors' Reply.

Jessica D Lee, Konstantinos Papamichael, Lauren T Grinspan

|Oct 23, 2025
Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease.

Jessica D Lee, Konstantinos Papamichael, Lauren T Grinspan

Pageof 7

Frequent Collaborators

7 joint publications

Adam S Cheifetz

3 joint publications

Jurij Hanzel

3 joint publications

Robert Battat

3 joint publications

Bram Verstockt